Overview
Carcinoma of the nasal meatus refers to malignant tumors originating within the nasal passages, encompassing various histological subtypes such as squamous cell carcinoma (SCC), neuroendocrine tumors (NET), adenocarcinoma, and undifferentiated carcinoma. These malignancies are clinically significant due to their potential for aggressive local invasion and distant metastasis, significantly impacting quality of life and survival rates. They predominantly affect older adults, with risk factors including chronic inflammation, smoking, and occupational exposures to carcinogens. Understanding the specific subtype and its genetic profile is crucial for tailoring effective therapeutic strategies, making accurate diagnosis and personalized treatment planning essential in day-to-day clinical practice 1.Pathophysiology
The pathophysiology of carcinoma in the nasal meatus involves complex interactions at molecular, cellular, and tissue levels. Initiating events often include genetic mutations that disrupt normal cellular regulation, leading to uncontrolled proliferation. Commonly implicated genes include TP53 and KMT2D, which are frequently mutated across different subtypes, contributing to genomic instability and tumor progression 1. In squamous cell carcinomas, additional mutations like those in EGFR and RICTOR further drive malignant transformation by enhancing cell survival and proliferation pathways. Neuroendocrine tumors, on the other hand, may arise from neuroendocrine cells and often exhibit distinct genetic alterations that promote hormone production and aggressive behavior. These molecular aberrations not only dictate the biological behavior of the tumor but also influence its response to therapeutic interventions, underscoring the importance of genomic profiling in guiding treatment decisions 1.Epidemiology
The incidence of nasal carcinomas varies geographically but generally affects older populations, with a slight male predominance. Squamous cell carcinomas are the most prevalent subtype, followed by neuroendocrine tumors and adenocarcinomas. Specific incidence rates are not uniformly reported across global databases, but trends indicate an increasing recognition due to improved diagnostic techniques and population aging. Occupational exposures, particularly to wood dust, leather dust, and certain chemicals, are notable risk factors, alongside smoking and alcohol consumption. While precise prevalence figures are lacking in the provided sources, these risk factors highlight the need for targeted screening and preventive measures in high-risk groups 13.Clinical Presentation
Patients with carcinoma of the nasal meatus typically present with nonspecific symptoms such as nasal obstruction, epistaxis (nosebleeds), facial pain, and anosmia (loss of smell). Advanced cases may exhibit more severe symptoms including facial swelling, diplopia (double vision), and cranial nerve palsies, particularly involving the optic and trigeminal nerves. Red-flag features include rapid progression of symptoms, significant weight loss, and signs of systemic metastasis, such as lymphadenopathy or neurological deficits. These presentations necessitate prompt diagnostic evaluation to differentiate from benign conditions and guide appropriate management 14.Diagnosis
The diagnostic approach for carcinoma of the nasal meatus involves a combination of clinical evaluation, imaging, and histopathological analysis. Initial steps include thorough history taking and physical examination, often supplemented by endoscopic assessment to visualize the nasal cavity. Imaging studies, particularly CT and MRI scans, are crucial for staging and assessing the extent of local invasion and potential metastasis. Definitive diagnosis relies on biopsy samples analyzed via histopathological examination, which may require immunohistochemical staining to differentiate between subtypes accurately. Specific criteria and tests include:Management
Primary Treatment
Adjuvant and Salvage Therapy
Monitoring and Management of Complications
Complications
Prognosis & Follow-up
Prognosis varies significantly based on tumor stage, histological subtype, and response to treatment. Early-stage disease generally has better outcomes, with 5-year survival rates ranging from moderate to high depending on subtype. Key prognostic indicators include the extent of local invasion, presence of lymph node metastasis, and molecular profiles such as TP53 and EGFR mutations. Recommended follow-up intervals include:Special Populations
Key Recommendations
References
1 Nagano H, Kiyama S, Takayuki K, Matsumoto H, Yamashita M. Genetic mutations in recurrent and/or metastatic nasal carcinoma: A pathological comparison based on the Japanese national genomic profiling database. Otolaryngologia polska = The Polish otolaryngology 2026. link 2 Takeshita A, Matsunaga K, Morita Y, Matsumiya Y, Okumura M, Satake H et al.. Reconstruction of nasal tip using auricular cartilage to prevent depression following midline partial maxillectomy: A report of two cases. Journal of stomatology, oral and maxillofacial surgery 2025. link 3 Cancedda S, Sabattini S, Bettini G, Leone VF, Laganga P, Rossi F et al.. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma. Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 2015. link 4 van Hemert FJ, de Bree R, Leemans CR, Middelweerd MJ. Gangplank flap reconstruction of the nose. Archives of facial plastic surgery 2007. link